Compliance with antihypertensive therapy among elderly medicaid enrollees: The roles of age, gender, and race

American Journal of Public Health

Volumn 86, Issue 12, 1996, Pages 1805-1808

  Monane, Mark ^a   Bohn, Rhonda L ^b   Gurwitz, Jerry H ^b   Glynn, Robert J ^b   Levin, Raisa ^b   Avorn, Jerry ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; ELDERLY CARE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICAID; ODDS RATIO; PATIENT COMPLIANCE; SELF ADMINISTRATION; SEX FACTORS; UNITED STATES;

EID: 0030476466     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.86.12.1805     Document Type: Article

References (50)

1. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension. 1994;23:275-285.
2. Kaplan NM. The appropriate goals of antihypertensive therapy: neither too much nor too little. Ann Intern Med. 1992;116:686-690.
3. Insua JT, Sacks HS, Lau TS, et al. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med. 1994;121: 355-362.
4. Fridinger FW, Jackson AW, Andresen J. A comparison of results of a national cholesterol and blood pressure screening with the NHANES II study: implications for further emphasis on reducing cardiovascular risk among Americans. J Community Health. 1992;17:247-257.
5. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:1768-1774.
6. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153:1863-1868.
7. Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc. 1982;30:329-333.
8. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med. 1989;321:303-309.
9. Haynes RB, Gibbon ES, Taylor DW, Bernholz CD, Sackett DL. Process versus outcome in hypertension: a positive result. Circulation. 1982;65:28-33.
10. Caldwell JR, Cobb S, Dowling MD, de Jongh D. The dropout problem in antihypertensive treatment. J Chronic Dis. 1970; 22:579-592.
11. Wilber JA, Barrow JG. Hypertension - a community problem. Am J Med. 1972;52: 653-663.
12. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am. 1989;73:1551-1563.
13. Haynes RB. A critical view of the determinants of patient compliance with therapeutic regimens. In: Sackett DL, Haynes RB, eds. Compliance with Therapeutic Regimens. Baltimore, Md: Johns Hopkins University Press; 1976;26-39.
14. Hammel RW, Williams PO. Do patients receive prescribed medication? Am Pharm Assoc J. 1964;4:331-337.
15. Darnell JC, Murray MD, Martz BL, Weinberger M. Medication use by ambulatory elderly: an in-home survey. J Am Geriatr Soc. 1986;34:1-4.
16. Amery A, Brixto P, Clement D, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;2:1349-1354.
17. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug therapy in older persons with systolic hypertension. JAMA. 1991;265:3255-3264.
18. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Older Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
19. Psaty BM, Savage PJ, Tell GS, et al. Temporal patterns of antihypertensive medication use among elderly patients. JAMA. 1993;270:1837-1841.
20. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993;83:711-716.
21. Monane M, Bohn R, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994;154:433-437.
22. Drug Facts and Comparisons: 1991 Edition. St Louis, MO: JB Lippincott Co; 1991.
23. Drug Evaluations. Chicago, III: American Medical Association; 1991.
24. Cox DR. Analysis of Binary Data. London, Eng: Chapman and Hall; 1970.
25. SAS Institute Inc. The CATMOD Procedure. In: SAS/STAT User's Guide. Release 6.03 ed. Cary, NC: SAS Institute; 1988:405-517.
26. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons; 1989.
27. Rosner B. Hypothesis testing: categorical data. In: Fundamentals of Biostatistics. Boston, Mass: PWS Publishers; 1986:302-367.
28. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993;118:201-220.
29. Heathy People 2000 report: heart disease and stroke. In: Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: US Dept of Health and Human Services; 1991:391-414. DHHS Publication PHS 91-50212.
30. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalisations of the elderly Arch Intern Med. 1990;150:841-845.
31. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MF, Sullivan S.R. Underutilization of antihypertensive drugs and associated hospitalization. Med Care. 1989;27:1159-1166.
32. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 1994;32:214-226.
33. Strandberg LR. Drugs as a reason for nursing home admissions. J Am Health Care Assoc. 1984;10:20-23.
34. Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health. 1992;82: 243-248.
35. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
36. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V).Arch Intern Med. 1993;153: 154-183.
37. Rosner B, Polk BF. The implications of blood pressure variability for clinical and screening purposes. J Chronic Dis. 1979;32: 451-461.
38. Fletcher AE, Franks PJ, Bulpitt CJ. The effect of withdrawing antihypertensive therapy: a review. J Hypertens. 1988;6:431-436.
39. Lessler JT, Harris BSH. Medicaid Data as a Source for Postmarketing Surveillance Information. Vol I: Technical Report. Research Triangle Park, NC: Research Triangle Institute; 1984. Final report.
40. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity. N Engl J Med. 1987;317:550-556.
41. Gurwitz JH, Bohn R, Glynn R, Monane M, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993;118:273-278.
42. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Choodnovskiy I, Avorn J. Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994;55:76-83.
43. Gurwitz JH, Avorn J, Bohn R, Glynn R, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994;272:781-786.
44. Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J. Medication choices for treatment of hypertension: the decline of the thiazides. Hypertension. 1995;25:1045-1051.
45. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11:1-47.
46. Ada LA, Anderson R. The national profile of access to medical care: where do we stand? Am J Public Health. 1984;74:1331-1339.
47. James SA, Wagner EH, Strogatz DS, et al. The Edgecombe County high blood pressure control program: II. barriers to the use of medical care among hypertensives. Am J Public Health. 1984;74:468-472.
48. Crawford SL, McGraw SA, Smith KW, McKinlay JB, Pierson JE. Do blacks and whites differ in their use of health care for symptoms of coronary artery disease? Am J Public Health. 1994;84:957-964.
49. Wenneker MB, Epstein AM. Racial inequalities in the use of procedure for patients with ischemic heart disease in Massachusetts. JAMA. 1989;261:253-257.
50. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.